MyAverix Finance
SHE · Healthcare
Tianjin Chase Sun Pharmaceutical Co Ltd (300026)
Drug Manufacturers - Specialty & Generic
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300026
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — FAQ
What is 300026's P/E ratio?
The price-to-earnings (P/E) ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (300026) is 18.00 (data as of 2026-05-24).
Does Tianjin Chase Sun Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tianjin Chase Sun Pharmaceutical Co Ltd (300026). Check the MyAverix Finance app for the latest dividend data.
What sector is Tianjin Chase Sun Pharmaceutical Co Ltd in?
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300026 listed on?
300026 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.